Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00247234 |
Recruitment Status
:
Completed
First Posted
: November 1, 2005
Last Update Posted
: September 25, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Personality Disorder, Borderline Avoidant Personality Disorder | Behavioral: Schema Therapy Behavioral: standard care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 90 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder |
Actual Study Start Date : | September 2004 |
Actual Primary Completion Date : | June 2011 |
Actual Study Completion Date : | January 2015 |

Arm | Intervention/treatment |
---|---|
Experimental: schema therapy |
Behavioral: Schema Therapy
group based schema therapy
|
Active Comparator: standard care
standard psychiatric out-patient care
|
Behavioral: standard care
standard psychiatric out-patient care
|
- quality of life [ Time Frame: 5 years ]Self-report measures
- depression [ Time Frame: 5 years ]Self-report measures
- anxiety [ Time Frame: 5 years ]Self-report measures
- suicidal ideation [ Time Frame: 5 years ]Self-report measures
- Use of psychotropic medication [ Time Frame: 5 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Avoidant or Borderline personality disorders
Exclusion Criteria:
- Do not speak Scandinavian languages
- Antisocial personality disorder
- Narcissistic personality disorder
- Affective bipolar disorder I
- Schizophrenia
- Mental impairment/organic brain disorder
- Substance dependence
- Planned pregnancy
- Serious somatic illness
- Anorexia Nervosa

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247234
Norway | |
St. Olavs Hospital | |
Trondheim, Norway, 7030 |
Study Chair: | Are Holen, M.D., Ph.D. | Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway |
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT00247234 History of Changes |
Other Study ID Numbers: |
ursula.falkmer+AEA-stolav.no |
First Posted: | November 1, 2005 Key Record Dates |
Last Update Posted: | September 25, 2017 |
Last Verified: | September 2017 |
Studies a U.S. FDA-regulated Drug Product: | No | |
Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
Disease Personality Disorders Borderline Personality Disorder Pathologic Processes Mental Disorders |